1. Home
  2. BPTH vs JFBR Comparison

BPTH vs JFBR Comparison

Compare BPTH & JFBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPTH
  • JFBR
  • Stock Information
  • Founded
  • BPTH 2007
  • JFBR 2017
  • Country
  • BPTH United States
  • JFBR Israel
  • Employees
  • BPTH N/A
  • JFBR N/A
  • Industry
  • BPTH Biotechnology: Pharmaceutical Preparations
  • JFBR Other Specialty Stores
  • Sector
  • BPTH Health Care
  • JFBR Consumer Discretionary
  • Exchange
  • BPTH Nasdaq
  • JFBR Nasdaq
  • Market Cap
  • BPTH 4.8M
  • JFBR 4.8M
  • IPO Year
  • BPTH N/A
  • JFBR 2022
  • Fundamental
  • Price
  • BPTH $0.73
  • JFBR $2.19
  • Analyst Decision
  • BPTH Strong Buy
  • JFBR
  • Analyst Count
  • BPTH 2
  • JFBR 0
  • Target Price
  • BPTH $30.00
  • JFBR N/A
  • AVG Volume (30 Days)
  • BPTH 161.7K
  • JFBR 390.3K
  • Earning Date
  • BPTH 03-07-2025
  • JFBR 04-02-2025
  • Dividend Yield
  • BPTH N/A
  • JFBR N/A
  • EPS Growth
  • BPTH N/A
  • JFBR N/A
  • EPS
  • BPTH N/A
  • JFBR N/A
  • Revenue
  • BPTH N/A
  • JFBR $12,335,000.00
  • Revenue This Year
  • BPTH N/A
  • JFBR N/A
  • Revenue Next Year
  • BPTH N/A
  • JFBR N/A
  • P/E Ratio
  • BPTH N/A
  • JFBR N/A
  • Revenue Growth
  • BPTH N/A
  • JFBR 66.98
  • 52 Week Low
  • BPTH $0.59
  • JFBR $0.17
  • 52 Week High
  • BPTH $10.00
  • JFBR $3.96
  • Technical
  • Relative Strength Index (RSI)
  • BPTH 37.30
  • JFBR 42.40
  • Support Level
  • BPTH $0.78
  • JFBR $2.18
  • Resistance Level
  • BPTH $0.84
  • JFBR $2.34
  • Average True Range (ATR)
  • BPTH 0.05
  • JFBR 0.16
  • MACD
  • BPTH -0.02
  • JFBR -0.04
  • Stochastic Oscillator
  • BPTH 4.05
  • JFBR 31.75

About BPTH Bio-Path Holdings Inc.

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

About JFBR Jeffs' Brands Ltd

Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.

Share on Social Networks: